REGISTER HERE.

Registration will close on February 26, 2021 at 5 p.m.

This virtual symposium will have expert review of the latest procedures, technology and medical treatments for GI cancer patients. National guidelines will be reviewed. Emphasis will be on multi-disciplinary care, novel new drugs that have been recently FDA-approved, and upcoming clinical trials. This symposium is for physicians, nurse practitioners, physician assistants, pharmacists, and oncology nurses who care for cancer patients. 

EDUCATIONAL OBJECTIVES

Upon completion of this education activity, learners should be able to:

• Recognize the multi-disciplinary approach (interventional radiology, surgery, radiation oncology, and medical oncology) to treating GI cancers
• Identify and use the new oncologic drugs for GI cancers and know the ongoing clinical trials
• Incorporate multi-disciplinary approach towards their patient care and offer an increased number of treatment options for the patients.

TARGETED AUDIENCE

This activity is intended for physicians, nurse practitioners, physician assistants, pharmacists and oncology nurses. Trainees, at all levels, are highly encouraged to attend.

ACCREDITATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.